Menu
Back to Journals » Therapeutics and Clinical Risk Management » Volume 14
Review
Ertugliflozin: a sodium-glucose cotransporter-2 (SGLT-2) inhibitor for glycemic control in type 2 diabetes
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 11,029 | Dovepress* | 9,827+ | 1,515 | 11,342 | |
| PubMed Central* | 1,202 | 431 | 1,633 | ||
| Totals | 11,029 | 1,946 | 12,975 | ||
| *Since 7 September 2018 | |||||
View citations on PubMed Central and Google Scholar